⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 28, 2026

Diprosalic - dermatologische Lösung (Lösung zur Anwendung auf der Haut)

📷 Wikipedia: Betamethasone dipropionate · Source
Diprosalic - dermatologische Lösung (Lösung zur Anwendung auf der Haut)
📷 Wikipedia: Betamethasone dipropionate · Source
Diprosalic - dermatological solution (solution for skin application) Parallel export is banned due to manufacturing capacity shortages. Affected packs: one box, bottle [unavailable since 26 August 2026, restock 26 November 2026]; one box, bottle [available].
⚠️
Shortage ongoing
BETAMETHASON DIPROPIONAT is currently in short supply in AT.
📈 Timeline
13 days active so far
August 29, 2026 September 10, 2026

What is this? Diprosalic is a skin lotion used for rashes and skin problems. It contains two medicines: betamethasone and salicylic acid.

What's happening? There is not enough Diprosalic lotion being made right now. Some packs are not available, but others can still be bought.

Does this affect me? If you use Diprosalic lotion, you might have trouble finding it in Austria.

What should I do? Ask your pharmacist or doctor for advice before you run out.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: D07XC01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Organon Healthcare GmbH, Pestalozzistraße 31, 80469 München, Federal Republic of Germany · Affected packs: 1 Stück Schachtel, Flasche [Nicht verfügbar, since 2026-08-26, resupply 2026-11-26] · 1 Stück Schachtel, Flasche [verfügbar]

First published
August 28, 2026
Last refreshed by us
17 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Diprosalic - dermatologische Lösung (Lösung zur Anwendung auf der Haut). Diprosalic - dermatological solution (solution for skin application) Parallel export is banned due to manufacturing capacity shortages. Affected packs: one box, bottle [unavailable since 26 August 2026, restock 26 November 2026]; one box, bottle [available].
When was this alert issued?
This alert was issued on August 28, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.